Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/11/1992 | CA2093646A1 Bis-benzo cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use |
04/11/1992 | CA2071513A1 Brain resuscitation device and method |
04/11/1992 | CA2053005A1 Emulsifier-free emulsion polymers |
04/11/1992 | CA2052950A1 Aqueous ophthalmic microemulsions of tepoxalin |
04/11/1992 | CA2052894A1 Use of substituted 2-mercaptonicotinic acid derivatives for combating endoparasites, new substituted 2-mercaptonicotinic acid derivatives and processes for their preparation |
04/11/1992 | CA2046211A1 Composition for therapeutic, prophylactic or diagnostic use in connection with infections |
04/10/1992 | WO1992006992A2 New process for biophosphorylating organic compounds |
04/10/1992 | WO1992006192A1 Inhibition of viral replication |
04/10/1992 | WO1992006136A1 Quaternary ammonium salts derived from chitosan |
04/10/1992 | WO1992006092A1 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
04/10/1992 | WO1992006084A1 Chromans and thiochromans with retinoid-like activity |
04/10/1992 | CA2093816A1 Inhibition of viral replication |
04/10/1992 | CA2093429A1 Process for biophosphorylating organic compounds |
04/10/1992 | CA2092178A1 Chromans and thiochromans with retinoid-like activity |
04/10/1992 | CA2091763A1 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
04/09/1992 | WO1992006094A1 Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |
04/09/1992 | WO1992005774A1 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
04/09/1992 | DE4031881A1 Solvent-free oral pharmaceutical prepn. |
04/09/1992 | DE4031821A1 Verwendung von thromboxan-a2-rezeptoren-antagonisten gegen proliferative veraenderungen in der gefaesswand Use of thromboxane a2-adrenergic receptor antagonists to induce proliferative border ments in the gefaesswand |
04/09/1992 | CA2052921A1 Sulfonamides as antifungal agents |
04/08/1992 | EP0479665A2 1,4-Dihydropyridine derivatives, method for preparing the same and use thereof |
04/08/1992 | EP0479640A2 Novel phosphonate derivatives of certain nucleosides |
04/08/1992 | EP0479631A1 Spiro[4,5]decane derivatives, process for their preparation and pharmaceutical compositions containing them |
04/08/1992 | EP0479574A2 2-(3-pyridyl)-carbapenem antibacterial agents |
04/08/1992 | EP0479570A2 Animal growth promotion with aromatase inhibitors |
04/08/1992 | EP0479546A2 Piperazine derivatives |
04/08/1992 | EP0479524A1 Method to reduce intraocular pressure without causing miosis |
04/08/1992 | EP0479518A1 Compositions for topical application |
04/08/1992 | EP0479505A1 Pradimicins L and FL and derivatives thereof |
04/08/1992 | EP0479480A2 Substituted thieno(2,3-B)(1,4)thiazine-6-sulfonamides as antiglaucoma agents |
04/08/1992 | EP0479479A1 Imadazole angiotensin II antagonists incorporating acidic functional groups |
04/08/1992 | EP0479356A1 Fungicidal compositions and method |
04/08/1992 | EP0479336A1 Antiviral compounds |
04/08/1992 | EP0479332A2 Diphenyl-methane derivative, pharmaceutical composition and use |
04/08/1992 | EP0479178A2 4- or 5-substituted pyridine-2-carboxylic acids, process for their preparation and their use as medicaments |
04/08/1992 | EP0479177A2 4- or 5-substituted pyridine-2-carboxylic acids, process for their preparation and their use as medicaments |
04/08/1992 | EP0479175A1 Pradimicin derivatives |
04/08/1992 | EP0479093A1 Oligosaccharide derivatives and their use as medicaments |
04/08/1992 | EP0479066A2 Methods of preparing stable injectable soluble forms of beta-carotene |
04/08/1992 | EP0479005A1 Gel composition in a dispenser |
04/08/1992 | EP0478954A1 Serotonin 5HT1A and 5HT1D antagonists |
04/08/1992 | EP0478941A1 Pharmaceuticals containing substituted cyclohex-2-en-1-yl-amine derivatives and their use in combatting diseases |
04/08/1992 | EP0478910A2 3-Substituted-aminomethyl-3-substituted-oxy-17A-methyl-17A-lower-alkyl-17A-aza-d-homo-5-alpha-androstanes |
04/08/1992 | EP0478874A2 Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them |
04/08/1992 | EP0478838A1 Compositions containing ibuprofen and S-(+)-ibuprofen, and process to prepare them |
04/08/1992 | EP0478837A1 Lactulose preparation and its manufacturing process |
04/08/1992 | EP0478787A1 Novel process for producing benzoic acid derivative |
04/08/1992 | EP0478778A1 Antitussive |
04/08/1992 | EP0478775A1 Peptide derivatives |
04/08/1992 | EP0478732A1 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
04/08/1992 | EP0478721A1 New benzocycloalkene carboxylic acid and process for producing it. |
04/08/1992 | EP0478708A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers |
04/08/1992 | EP0478702A1 Encapsulation process. |
04/08/1992 | EP0478677A1 Novel cyclodextrin inclusion complexes |
04/08/1992 | EP0478660A1 Pharmaceutical compositions and methods for treating inflammation |
04/08/1992 | EP0478558A1 An improved process for the preparation of substituted isoflavone derivatives. |
04/08/1992 | EP0478545A1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
04/08/1992 | EP0344158B1 Pain-killer |
04/08/1992 | EP0307400B1 Inhibitors of esterase-producing micro-organisms, for use primarily in deodorant compositions |
04/08/1992 | EP0282507B1 Discorhabdin compositions and their methods of use |
04/08/1992 | EP0268581B1 Prostacyclines, their analogues or prostaglandines and thromboxane antagonists for the treatment of thrombotic and thrombo-embolic illnesses |
04/08/1992 | EP0229844B1 Fat emulsion of prostaglandin i 2? |
04/08/1992 | EP0204737B1 Preparations for the intramuscular injection of drugs, vitamins or vaccines |
04/08/1992 | CN1060094A Heterocyclic compounds |
04/08/1992 | CN1060093A 1-methylcarbapenem derivatives and process for preparation thereof |
04/08/1992 | CN1060092A Calcium uptake inhibitors |
04/08/1992 | CN1060024A Preparing method for apovincamine acid ethyl ester |
04/08/1992 | CN1016176B Synthesis of 2-aminopyridmido (4,5-g) quinolines |
04/08/1992 | CN1016175B Preparation for imidazoquinoline antithombogehic cardiotonic agents |
04/08/1992 | CN1016174B Preparation of pyrido (2,3-d) pyrimidine derivatives |
04/08/1992 | CN1016173B Novel (aryl or hetervaromatic methyl) -2,2'-bi-1h-imidazoles process |
04/08/1992 | CN1016170B Pocess for preparing allyaminoethylazole |
04/08/1992 | CN1016169B Process for preparing imidazole derivatives |
04/07/1992 | US5103023 Carboxy derivates with oxy subsitituents for treating liuer disorders |
04/07/1992 | US5103013 Dithioketene derivatives, pharmaceutical compositions containing the same and uses thereof |
04/07/1992 | US5103010 Anticoagulant |
04/07/1992 | US5102997 2-(1-acetimidoyl-5-carbamoylpyrrolidin-3-ylthio-6-(1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylic acid |
04/07/1992 | US5102914 Racemic mixtures |
04/07/1992 | US5102913 Treatment for cocaine use employing valproic acid |
04/07/1992 | US5102912 Hydroxyoctadecadienic acid for the treatment of estrogen-dependent disease |
04/07/1992 | US5102910 Mixture of asparginic acid, cycteine, glutaminic acid, sodium selenate and zinc acetate or sulfate |
04/07/1992 | US5102908 Method of treating Acquired Immunedeficiency Syndrome (AIDS) using organic tellurium and selenium derivatives |
04/07/1992 | US5102906 Alzheimer*s disease |
04/07/1992 | US5102905 For treating side effects of diabetes and galactosemia |
04/07/1992 | US5102903 Treatment of glaucoma and ocular hypertension with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists |
04/07/1992 | US5102902 Orally administering a composition including cemetidine while controlling the frequency of dosage |
04/07/1992 | US5102901 New 3-n substituted carbamoyl-indole derivatives |
04/07/1992 | US5102900 Imidazoles useful as antiatherosclerotic agents |
04/07/1992 | US5102897 3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues |
04/07/1992 | US5102896 Nootropic agents |
04/07/1992 | US5102895 Novel vitamin e derivatives and process for the production thereof |
04/07/1992 | US5102894 Antihyporic, antiischemic, antiepileptic agents |
04/07/1992 | US5102892 Antisecretory agent for gastrointestinal disorders |
04/07/1992 | US5102891 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates |
04/07/1992 | US5102889 2-(4-piperidinyl)-1H-pyrido[4,3-b]indol-1-ones and related compounds |
04/07/1992 | US5102888 Quinoline type mevalonolactones useful for treating hyperlipidemia and related diseases |
04/07/1992 | US5102887 Method for reducing emesis and nausea induced by the administration of an emesis causing agent |
04/07/1992 | US5102886 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors |
04/07/1992 | US5102885 Anticonvulsants, anxiolytic agents, cognition activators |
04/07/1992 | US5102883 Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents |